Peptilogics is a clinical-stage biotechnology company that designs and develops novel peptide therapeutics. Through their computational platform, Peptilogics is radically altering drug discovery by not only uncovering new, previously unexplored chemical design space, but ensuring that each potential therapeutic is biologically viable and scalable to manufacture. Peptilogics' lead clinical stage peptide therapeutic, PLG0206, is a novel, broad-spectrum anti-infective that has been granted FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections, an unmet medical need.

Biotechnology

Peptilogics

Jonathan Steckbeck

Marc Lesnick

Albert Fonticiella

Steve Kulp

Atul Deshpande Ph.d.

David Huang

Bradd Picone

Nicholas Pachuda

Nick Nystrom

Senior Management

Leadership Team

Research and Development Team

Teams at Peptilogics

Senior Management

Leadership Team

Research and Development Team